Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Progesterone reduces spinal reflex activity by increasing certain GABA(A) receptor subtypes.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

New progesterone-based compounds can block male hormones.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Laser-assisted prostaglandin analogs improve hypopigmented scars safely, but more research is needed.

Megestrol acetate helps fat-derived stem cells grow, move, and turn into fat cells through a specific receptor.

Targeting the PGD2-DP2 pathway may help treat hair loss.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Bimatoprost effectively promotes hair growth.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Topical prostaglandin analogs may help with hair growth but more research is needed.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

Synthetic 19-norprogestins promote bone cell growth and function through their non-phenolic metabolites.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Latanoprost can make eyelashes longer, thicker, and darker.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

Dienogest is safer and has fewer side effects than GnRH analogues for treating endometriosis.

Topical prostaglandin analogues may improve hair density in androgenetic alopecia, but more research is needed.